A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Abroad (travel likely)RecruitingPHASE3
Conditions
Muscular Atrophy, Spinal
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Nancy Kuntz)Neurology Rare Disease Center, Flower Mound, Texas, United States
Contact: Principal Investigator (Diana Castro)Childrens Hospital of the Kings Daughter Norfolk, Norfolk, Virginia, United States
Contact: Principal Investigator (Crystal Proud)Childrens Hospital of Fudan University_Shanghai, Shanghai, China
Japan Institute for Health Security National Center for Global Health and Medicine, Tokyo, Japan
Study leads
Medical Director
Study Director
Biogen